Post-authorisation safety study of NOCDURNA for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria: A multi-country cohort study using secondary data. (NOCDURNA PASS) First published 07/01/2021 Last updated 06/11/2024 EU PAS number:EUPAS38365 Study Finalised